Group One Trading
UBX

Group One Trading’s Unity Biotechnology UBX Stock Holding History

Group One Trading’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-39,600
Closed -$15K – 9191
2025
Q2 		$15K Buy
39,600
+15,900
+67% +$13.6K ﹤0.01% 6451
2025
Q1 		$24.6K Buy
23,700
+16,000
+208% +$28.9K ﹤0.01% 5677
2024
Q4 		$7.52K Sell
7,700
-1,500
-16% -$1.86K ﹤0.01% 6232
2024
Q3 		$13.5K Sell
9,200
-1,700
-16% -$2.5K ﹤0.01% 5456
2024
Q2 		$14.7K Sell
10,900
-20,400
-65% -$31K ﹤0.01% 5423
2024
Q1 		$51.3K Sell
31,300
-14,700
-32% -$25.5K ﹤0.01% 4694
2023
Q4 		$88.8K Sell
46,000
-93,400
-67% -$174K ﹤0.01% 4565
2023
Q3 		$335K Buy
139,400
+9,900
+8% +$26.2K ﹤0.01% 3329
2023
Q2 		$330K Buy
129,500
+119,900
+1,249% +$317K ﹤0.01% 3439
2023
Q1 		$15.6K Sell
9,600
-461,800
-98% -$1.85M ﹤0.01% 5673
2022
Q4 		$1.29M Buy
471,400
+424,760
+911% +$1.23M ﹤0.01% 2198
2022
Q3 		$184K Buy
46,640
+44,840
+2,491% +$283K ﹤0.01% 4228
2022
Q2 		$10K Sell
1,800
-4,410
-71% -$36.8K ﹤0.01% 6775
2022
Q1 		$70K Buy
6,210
+3,860
+164% +$43.3K ﹤0.01% 5839
2021
Q4 		$34K Sell
2,350
-4,120
-64% -$90K ﹤0.01% 6624
2021
Q3 		$194K Buy
6,470
+510
+9% +$18K ﹤0.01% 5210
2021
Q2 		$277K Buy
5,960
+1,260
+27% +$60.7K ﹤0.01% 4875
2021
Q1 		$282K Buy
4,700
+1,740
+59% +$119K ﹤0.01% 4650
2020
Q4 		$155K Buy
2,960
+2,110
+248% +$102K ﹤0.01% 4252
2020
Q3 		$29K Buy
850
+790
+1,317% +$50K ﹤0.01% 4959
2020
Q2 		$5K Buy
+60
New +$4.45K ﹤0.01% 5385

Other funds holding UBX

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

Group One Trading's UBX Position: Q3 2025 in Review

Group One Trading sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 10,484 shares — an estimated $3.98K sold.

Group One Trading first reported a position in UBX in Q1 2019 and held it in 13 quarters. The position peaked at $188K in Q3 2020. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

  • Group One Trading reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 10,484 Unity Biotechnology shares in Q3 2025, an estimated $3.98K.
  • Group One Trading first reported a position in Unity Biotechnology in Q1 2019 and held it in 13 quarters.
  • Group One Trading's Unity Biotechnology position peaked at $188K in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.